Education
About Us
Working with TipRanks
Follow Us
Biora Therapeutics (BIORQ)
OTHER OTC:BIORQ
Total Valuation
Biora Therapeutics has a market cap or net worth of $1.11M. The enterprise value is ―.
Market Cap$1.11M
Enterprise Value―
Share Statistics
Biora Therapeutics has 4,522,702 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding4,522,702
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Biora Therapeutics’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee68.97
Profits Per Employee-2.14M
Employee Count58
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of Biora Therapeutics is ―. Biora Therapeutics’s PEG ratio is ―.
PE Ratio―
PS Ratio0.00
PB Ratio―
Price to Fair Value―
Price to FCF―
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, Biora Therapeutics had revenue of 4.00K and earned -124.11M in profits. Earnings per share was -7.87.
Revenue4.00K
Gross Profit4.00K
Operating Income-67.14M
Pretax Income-124.42M
Net Income-124.11M
EBITDA-114.05M
Earnings Per Share (EPS)-7.87
Cash Flow
In the last 12 months, operating cash flow was -5.37M and capital expenditures -280.00K, giving a free cash flow of -5.50M billion.
Operating Cash Flow-5.37M
Free Cash Flow-5.50M
Free Cash Flow per Share-1.22
Dividends & Yields
Biora Therapeutics pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.48
52-Week Price Change-95.87%
50-Day Moving Average0.15
200-Day Moving Average1.12
Relative Strength Index (RSI)76.42
Average Volume (3m)11.46K
Important Dates
Biora Therapeutics upcoming earnings date is Aug 18, 2025, TBA (Confirmed).
Last Earnings DateMay 7, 2025
Next Earnings DateAug 18, 2025
Ex-Dividend Date―
Financial Position
Biora Therapeutics as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, Biora Therapeutics has paid -90.00K in taxes.
Income Tax-90.00K
Effective Tax Rate―
Enterprise Valuation
Biora Therapeutics EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
Biora Therapeutics has $3.20M in cash and marketable securities with $39.65M in debt, giving a net cash position of $36.45M billion.
Cash & Marketable Securities$3.20M
Total Debt$39.65M
Net Cash$36.45M
Net Cash Per Share$8.06
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for Biora Therapeutics is $23.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$23.00
Price Target Upside7319.35% Upside
Analyst ConsensusHold
Analyst Count0
Revenue Growth Forecast4855.56%
EPS Growth Forecast88.66%